semaglutide gastrointestinal obstruction lawyer in dallas law office Wegovy Lawsuit Louisiana Rybelsus Lawsuit kentucky glp-1 digestive blockage lawyer

However, both medications suppress appetite and may affect cardiovascular function, requiring careful medical supervision and monitoring when used together

Semaglutide is a prescription peptide medication with no abuse potential and is not classified as a controlled substance by the Drug Enforcement Administration (DEA)

A total of 154 individuals were screened, 108 were randomized (54 to each group)

WeightCare and other medications Many people considering WeightCare semaglutide are also taking or considering other medications

There is theoretical concern that appetite suppression could transition binge eating patterns toward restrictive eating or trigger other eating disorder behaviors, though this has not been systematically studied

Rapid weight loss at this rate increases risk of gallstones, muscle loss, electrolyte imbalances, and cognitive impairment